Evidence map›Paper›PMID 42297379›Full record

ArticleBriefings in bioinformatics2026

SwiftTCR: efficient computational docking protocol of TCRpMHC-I complexes using restricted rotation matrices.

Farzaneh M Parizi, Yannick J M Aarts, Nils Smit, A R Dona Roran, Daniëlle Diepenbroek, Wieke A Krösschell, Levin Thijs, Joost Tepperik, Dario F Marzella, Gayatri Ramakrishnan and 1 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Farzaneh M PariziMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Yannick J M AartsMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Nils SmitHAN University of Applied Sciences, Kapittelweg 33-35 6503 GL, Nijmegen, the Netherlands.
A R Dona RoranMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Daniëlle DiepenbroekMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Wieke A KrösschellMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Levin ThijsMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Joost TepperikMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Dario F MarzellaMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Gayatri RamakrishnanMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Li C XueMedical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.ORCID 0000-0002-2613-538X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The T cell's ability to discern self and non-self depends on its T cell receptor (TCR), which recognizes peptides presented by major histocompatibility complexes (MHC) molecules. Understanding this TCR-peptide-MHC (TCRpMHC) interaction is important for cancer immunotherapy design, tissue transplantation, pathogen identification, and autoimmune disease treatments. Understanding the intricacies of TCR recognition, encapsulated in TCRpMHC structures, remains challenging due to the immense diversity of TCRs (>108/individual), rendering experimental determination, and general-purpose computational docking impractical. Addressing this gap, we have developed a rapid integrative modeling protocol leveraging unique docking patterns in TCRpMHC complexes. Built upon PIPER, our pipeline significantly cuts down Fast Fourier Transform rotation sets, exploiting the consistent polarized docking angle of TCRs at pMHC. Additionally, our ultra-fast structure superimposition tool, GradPose, accelerates clustering. It models a case in 3-4 min on 12 Central Processing Units (CPUs), showcasing a speedup of up to 25-40 times compared to the ClusPro webserver. On a benchmark set of 38 TCRpMHC class I (TCRpMHC-I) complexes, our protocol outperforms the state-of-the-art docking tools in model quality. This protocol can potentially provide structural information to TCR repertoires targeting specific peptides. Its computational efficiency can also enrich existing pMHC-specific single-cell sequencing TCR data, facilitating the development of structure-based deep learning algorithms. These insights are essential for understanding T cell recognition and specificity, advancing the development of therapeutic interventions.

Indexed as

ImmunoinformaticsMolecular Docking SimulationPeptidesReceptors, Antigen, T-CellSoftwareHumansProtein BindingPeptidesReceptors, Antigen, T-Cellcomputational immunologyintegrative modelingpeptide–MHC (pMHC)restricted dockingT cell receptor (TCR)TCR binding angle

Identifiers

PMID42297379
PMCPMC13267900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.